Role of procalcitonin in predicting severity and in-hospital mortality in patients with community-acquired pneumonia Source: International Congress 2016 – Community-acquired pneumonia: risk classes and management issues Year: 2016
Bacteremic vs. non-bacteremic pneumococcal pneumonia in immunocompetent patients: Predictive and prognostic factors Source: International Congress 2016 – Community-acquired pneumonia: from prevention to treatment Year: 2016
Predictive and prognostic factors in patients with blood-culture-positive community-acquired pneumococcal pneumonia Source: Eur Respir J 2016; 48: 797-807 Year: 2016
Clinical impact of a prediction score for drug-resistance in community-onset pneumonia Source: International Congress 2016 – Community-acquired pneumonia: from prevention to treatment Year: 2016
Comparison of the predictive performance of severity assessment tools in community-acquired or health care-associated pneumonia Source: Annual Congress 2013 –Manifestations, scores and prognosis of community-acquired pneumonia Year: 2013
The neutrophil/lymphocyte ratio in predicting outcome for hospitalized patients with community-acquired pneumonia Source: International Congress 2014 – Cells, biofilms and biomarkers in respiratory infections Year: 2014
Usefulness of shock index predictive value in mortality assessment in community acquired pneumonia Source: Annual Congress 2013 –Manifestations, scores and prognosis of community-acquired pneumonia Year: 2013
Comparison of the prognostic value of different severity scales in community- acquired pneumonia Source: International Congress 2014 – Epidemiology, scores and outcomes of respiratory infections Year: 2014
Value of bacteraemia as an unfavourable prognostic factor for community-acquired pneumonia Source: Eur Respir J 2006; 28: Suppl. 50, 350s Year: 2006
Community acquired legionella pneumophila pneumonia, clinical characteristics, outcomes and prognostic factors Source: International Congress 2015 – Clinical issues in CAP: microbiological and radiological determinants Year: 2015
The risk factors of clinical practice for bacteremia in community- acquired pneumococcal pneumonia Source: International Congress 2016 – Community-acquired pneumonia: from prevention to treatment Year: 2016
Biomarkers for the prognostic assessment and disease severity evaluation in community-acquired pneumonia (CAP) Source: Annual Congress 2010 - The prognosis of community-acquired pneumonia: old and new markers of severity Year: 2010
Prognostic value of plasma D-dimer level in adults with community-acquired pneumonia – A prospective study Source: International Congress 2015 – CAP: prognostic factors in frail patients Year: 2015
The assessment of prognostic rules in patients with community-acquired pneumonia (CAP) Source: Eur Respir J 2003; 22: Suppl. 45, 149s Year: 2003
The prognostic value of consecutive C-reactive protein measurements in community acquired pneumonia Source: International Congress 2015 – CAP: prognostic factors in frail patients Year: 2015
Biomarkers as complication predictors in community-acquired pneumonia Source: Annual Congress 2011 - Biomarkers and outcomes of community-acquired pneumonia Year: 2011
Prognostic factors of 30 day mortality in HIV infected patients with community-acquired pneumonia Source: International Congress 2014 – Interventions and other therapeutic approaches in respiratory infections Year: 2014
Prognostic factors of mortality in patients with community-acquired pneumonia (CAP) Source: Eur Respir J 2003; 22: Suppl. 45, 239s Year: 2003
Relationship between etiologic diagnosis and prognosis in community-acquired pneumonia Source: International Congress 2015 – Clinical issues in CAP: microbiological and radiological determinants Year: 2015
Clinical and laboratory predictors of survival in patients with severe community-acquired pneumonia (CAP) Source: International Congress 2014 – Healthcare, prevention and adjunctive treatments in respiratory infections Year: 2014